A detailed history of Buckingham Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 14,727 shares of MRK stock, worth $1.47 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
14,727
Previous 14,767 0.27%
Holding current value
$1.47 Million
Previous $1.83 Million 8.53%
% of portfolio
0.19%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$111.15 - $128.97 $4,446 - $5,158
-40 Reduced 0.27%
14,727 $1.67 Million
Q2 2024

Jul 15, 2024

BUY
$123.8 - $132.96 $11,142 - $11,966
90 Added 0.61%
14,767 $1.83 Million
Q1 2024

Apr 10, 2024

BUY
$113.24 - $131.95 $194,999 - $227,217
1,722 Added 13.29%
14,677 $1.94 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $102,183 - $111,200
1,020 Added 8.55%
12,955 $1.41 Million
Q3 2023

Oct 13, 2023

SELL
$102.95 - $114.33 $8,853 - $9,832
-86 Reduced 0.72%
11,935 $1.23 Million
Q2 2023

Jul 11, 2023

BUY
$108.61 - $118.38 $37,253 - $40,604
343 Added 2.94%
12,021 $1.39 Million
Q1 2023

Apr 11, 2023

BUY
$102.94 - $114.86 $87,499 - $97,631
850 Added 7.85%
11,678 $1.24 Million
Q4 2022

Jan 24, 2023

SELL
$87.44 - $112.11 $141,040 - $180,833
-1,613 Reduced 12.97%
10,828 $0
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $406,589 - $456,757
-4,810 Reduced 27.88%
12,441 $1.07 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $361,344 - $409,601
-4,328 Reduced 20.06%
17,251 $1.57 Million
Q1 2022

May 06, 2022

SELL
$73.51 - $82.4 $607,339 - $680,788
-8,262 Reduced 27.69%
21,579 $1.77 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $59,847 - $74,967
-828 Reduced 2.7%
29,841 $2.29 Million
Q3 2021

Nov 08, 2021

SELL
$71.68 - $78.83 $125,296 - $137,794
-1,748 Reduced 5.39%
30,669 $2.3 Million
Q2 2021

Jul 27, 2021

SELL
$70.31 - $77.77 $481,131 - $532,180
-6,843 Reduced 17.43%
32,417 $2.52 Million
Q1 2021

May 04, 2021

SELL
$68.86 - $81.11 $221,109 - $260,444
-3,211 Reduced 7.56%
39,260 $3.03 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $479,925 - $532,619
-6,687 Reduced 13.6%
42,471 $3.47 Million
Q3 2020

Nov 02, 2020

SELL
$73.18 - $82.95 $24,149 - $27,373
-330 Reduced 0.67%
49,158 $4.08 Million
Q2 2020

Jul 20, 2020

BUY
$70.42 - $80.13 $207,175 - $235,742
2,942 Added 6.32%
49,488 $3.83 Million
Q1 2020

May 06, 2020

SELL
$63.36 - $87.82 $844,715 - $1.17 Million
-13,332 Reduced 22.27%
46,546 $3.58 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $89,837 - $101,371
1,158 Added 1.97%
59,878 $5.45 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $192,558 - $209,895
-2,531 Reduced 4.13%
58,720 $4.94 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $367,428 - $429,244
-5,261 Reduced 7.91%
61,251 $5.14 Million
Q1 2019

May 07, 2019

SELL
$69.58 - $79.36 $206,443 - $235,461
-2,967 Reduced 4.27%
66,512 $5.53 Million
Q4 2018

Feb 04, 2019

BUY
$65.24 - $75.71 $207,267 - $240,530
3,177 Added 4.79%
69,479 $5.31 Million
Q3 2018

Nov 20, 2018

BUY
$57.69 - $67.84 $280,892 - $330,312
4,869 Added 7.93%
66,302 $4.7 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $66,079 - $77,636
1,300 Added 2.16%
61,433 $3.73 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $813,729 - $945,784
15,968 Added 36.16%
60,133 $3.28 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $389,266 - $464,827
7,541 Added 20.59%
44,165 $2.49 Million
Q3 2017

Nov 07, 2017

SELL
$58.67 - $63.13 $9,504 - $10,227
-162 Reduced 0.44%
36,624 $2.35 Million
Q2 2017

Aug 10, 2017

BUY
N/A
36,786
36,786 $2.36 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Buckingham Capital Management, Inc. Portfolio

Follow Buckingham Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.